A proportion of patients with epilepsy suffer from serial seizures or fits in clusters, that is, two or more fits in quick succession excluding status epilepticus. This condition leads to an increased morbidity from epileptic seizures and may herald true status epilepticus.' 2 Consequently, serial seizures should be controlled as soon as possible to prevent the development of more serious complications. Ideally, this requires an agent which is both effective and easily administered without the skills required for parenteral administration. Since many patients remain unconscious after a fit oral administration is often impractical and may also be ineffective although this has never been examined in a clinical trial. Recently, rectal administration of diazepam solution in children has been shown to be clinically effective in the acute treatment of seizures3 and in the prevention of recurrent febrile convulsions.4 When given rectally in adults diazepam solution significantly reduces the frequency of interictal spikes in the EEG& but the clinical value of such treatment is uncertain.
Diazepam suppositories provide a more convenient mode of drug administration but the results from previous pharmacokinetic studies have been disappointing and this may be related to the formulations used.67 Consequently the use of these suppositories in the treatment of adult patients with epilepsy has never been systematically examined. A new "solid solution" diazepam suppository was specifically designed to promote rapid release of the drug. This preparation has been shown to sup- positories had been used in a given subject they were replaced by another pair (one active, one placebo) for use in the same patient on subsequent occasions to ensure that those patients studied relatively infrequently had the opportunity of receiving both treatments and the first treatment of each pair was allocated randomly. Administration of suppositories and patient assessments were conducted by the attendant staff under double-blind conditions.
In a given patient, a single suppository was administered as soon as possible after a fit. The time and description of the fit were documented on record sheets provided together with the code number of the treatment given. Patients remained under observation for the next 24 h and all fits occurring during this time were accurately recorded. In the majority of cases a minimum wash-out period of 48 h was allowed between treatments although on a few occasions patients were studied more frequently when the opportunity presented (wash-out period 24-48 h). The nursing or medical staff were permitted to administer alternative treatment if seizures occurred frequently after administration of the suppository.
A single blood specimen (7 ml) was taken 60 min after administration of the suppository. When this was impractical samples were withdrawn at a more convenient time. These were subsequently analysed by gas value which adequately takes into account the multiple cross-over structure of the trial.
Oral diazepam study
Eighteen adult epileptic patients, mean age 38 years (range 21-60) and resident at the Chalfont Centre for Epilepsy, consented to take part in this study. All patients suffered from severe epilepsy with mixed seizure types and all subjects were prone to serial epilepsy or fits in clusters from which they were known to make a rapid recovery. This permitted treatment to be administered orally. Treatment consisted of diazepam tablets 20 mg and a matched placebo supplied by Roche Ltd. The study was conducted double-blind and the procedure was identical to that used in the previous study with the exception that treatment was administered orally. It was usually possible to administer tablets within 30 min of a fit and special care was taken to ensure that tablets were properly swallowed. 
